Home > Financial Ratios > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Core EBITDA Growth

    Back to All Ratios
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 39.1953.9668.0075.65-59.73

What is the latest Core EBITDA Growth ratio of KILITCH DRUGS (INDIA) ?

The latest Core EBITDA Growth ratio of KILITCH DRUGS (INDIA) is 39.19 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202439.19
Mar202353.96
Mar202268.00
Mar202175.65
Mar2020-59.73

How is Core EBITDA Growth of KILITCH DRUGS (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2024 39.19
-27.37
Mar2023 53.96
-20.65
Mar2022 68
-10.11
Mar2021 75.65
Positive
Mar2020 -59.73 -

Other Financial Ratios of KILITCH DRUGS (INDIA)


Compare Core EBITDA Growth ratio of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹492.7 Cr -0.7% -6% -12.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,246.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹147,119.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹116,805.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,554.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹93,192.0 Cr -0.9% -10% -11.3% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-0.7%

-6%

-12.9%

SENSEX

1.5%

-5.1%

0.6%


You may also like the below Video Courses